到 2030 年智能吸入器市场预测 - 按产品、按适应症（哮喘、慢性阻塞性肺疾病）、按分销渠道、按最终用户、按地区进行全球分析

据 Stratistics MRC 预测，到 2023 年，全球智能吸入器市场规模将达到 14.2 亿美元，预测期内復合年增长率为 9%，到 2030 年将达到 26 亿美元。

智能吸入器是通过蓝牙与移动应用程序配对的小工具，可有效管理慢性呼吸道疾病并改善患者的生活方式。 此外，根据用户过去的用药历史，这些智能设备可以发送提醒和警报。 哮喘、囊性纤维化和慢性阻塞性肺病等呼吸系统疾病正变得司空见惯，对智能吸入器的需求猛增。

根据世界卫生组织 2021 年报告，哮喘是一种主要的非传染性疾病 (NCD)，影响儿童和成人，2019 年估计有 2.62 亿人受到影响。2019 年有 461,000 人死亡。

市场动态：

驱动程序

哮喘患病率上升

由于空气污染和吸烟习惯的增加，哮喘和慢性阻塞性肺病变得越来越普遍，推动了市场对智能吸入器的需求。 ODPHP 疾病预防和健康促进办公室估计，2020 年全球将有超过 3.39 亿哮喘病例，其中 2500 万是美国人，1480 万将被诊断患有慢性阻塞性肺病。 哮喘是儿童和老年人最常见的疾病。 这种非传染性疾病正在通过吸烟习惯的增加和全球空气污染水平的上升而传播。

限制

数据洩露风险

由于智能吸入器的无线连接和记录患者数据的能力，数据洩露和滥用的风险显着增加。 此外，由于患者和医生的接受度很低，预计智能吸入器将阻碍市场扩张。

机会：

扩大数字技术在医疗设备中的使用

在预测期内，医疗设备和药物输送设备中数字技术的日益采用预计将加速市场增长。 除此之外，哮喘和慢性阻塞性肺病等呼吸系统疾病的患病率不断上升，预计将为增加数字吸入器的采用提供重要机会。 例如，美国疾病控制与预防中心 (CDC) 的一项研究估计，2016 年美国有 2650 万哮喘患者。 上述因素可能会极大地刺激这些智能吸入器的市场扩张。

威胁

存在替代手动吸入器

儘管智能吸入器的好处越来越大，但手动吸入器作为替代产品的存在可能会在一定程度上限制市场的扩张。 阻碍智能吸入器市场扩张的另一个关键因素是新兴经济体民众对数字吸入器的使用缺乏认识。

COVID-19 的影响：

COVID-19 的全球爆发预计将为智能吸入器领域的市场进入者带来利润丰厚的增长机会。 此次疫情对市场产生了积极影响，因为 COPD 和哮喘患者因 COVID-19 而面临更高的住院风险。 因此，在此期间，COVID-19 患者数量的不断增加和呼吸系统疾病的负担增加了智能吸入器的需求和采用。

医院药房业务预计将在预测期内成为最大的业务：

预计在预测期内，医院药房部门将占据最大的市场份额。 在医院接受治疗的患者可以轻鬆前往医院药房。 此外，许多给药系统製造商与医院药房有销售协议。 因此，在预测期内，上述因素强烈表明销售智能吸入器的医院药房市场将遵循积极的增长轨迹。

慢性阻塞性肺疾病 (COPD) 领域预计在预测期内復合年增长率最高：

由于全球慢性阻塞性肺病患者数量不断增加，预计未来几年市场增长将带来丰厚回报。 例如，世界卫生组织 (WHO) 估计，慢性阻塞性肺病是 2019 年全球第三大死亡原因，夺去了超过 323 万人的生命。 此外，许多风险因素，包括长期吸烟、室内空气污染、有害气体和颗粒物以及职业粉尘，都会影响慢性阻塞性肺病的患病率，需要持续的护理管理。 因此，慢性阻塞性肺病患病率的上升和对有效治疗的需求不断增长将在预测期内推动该细分市场的需求。

市场份额最大的地区

由于该地区国家主要市场参与者的活动增加，预计北美地区市场在预测期内将占据全球智能货架市场的最高份额。 北美智能货架市场包括引入和部署采用先进技术的智能货架系统，以在零售环境中提供增强的购物体验、改进的库存管理和实时数据分析。 北美零售商越来越多地采用自动化和数字化来简化运营并提高客户参与度。 智能货架可实现实时库存跟踪，因此零售商可以优化库存水平、减少缺货并提高整体库存管理效率。

复合年增长率最高的地区：

由于人口老龄化严重、可支配收入增加、医疗保健成本上升以及一系列发展举措，亚太地区预计将经历快速增长。 新兴经济体不断增加的医疗保健 IT 开发支出也促进了该地区的增长。 此外，印度和中国的亚太智能吸入器市场预计将快速增长。

主要进展：

2023 年 6 月，H&T Presspart 计划进一步投资 L'Arboc。 全球供应的万託林定量吸入器执行器是在塔拉戈纳的 L'Arboc (Baix Penedes) 製造的。 H&T Presspart 年产注塑塑料给药部件和装置合计超过 10 亿件，过去两年在 Larboc 工厂投资超过 2000 万欧元，将产能扩大到 3,000 平方米的洁净厂房我们扩大了生产设施。

2023 年2 月，Teva Pharmaceutical Industries Ltd. 的美国子公司Teva Pharmaceuticals USA, Inc. 宣布将参加2 月24 日至27 日在德克萨斯州圣安东尼奥举行的美国过敏、哮喘和免疫学大会。 (AAAAI) 宣布将在 2023 年年会上展示有关 Digihaler 系统的新数据。 这些数据包括 CONNECT2 临床试验计划的结果，以及患者和医疗保健专业人员在现实世界中使用智能吸入器系统的信息。 Digihaler 系统是第一个也是唯一一个带有内置传感器的智能吸入器系统，可提供客观的吸入事件数据，帮助患者和医生支持哮喘管理并製定个性化的治疗计划。

2022年12月，澳大利亚医用大麻公司ECS Botanics宣布将为药用干花供应蒸发器装置。 该公司表示，已签署一项协议，从一家未具名的公司进口和供应智能计量吸入器及相关软件。

报告内容

• 区域和国家级细分市场的市场份额评估
• 给新进入者的战略建议
• 2021 年、2022 年、2023 年、2026 年和 2030 年的综合市场数据
• 市场趋势（市场驱动因素、干扰因素、机遇、威胁、挑战、投资机会/驱动因素和建议）
• 根据市场预测提出关键业务领域的战略建议
• 竞争格局绘製主要共同趋势
• 公司简介，包括详细的战略、财务状况和最新发展
• 供应链趋势映射最新技术趋势

免费定制服务：

订阅此报告的客户将获得以下免费自定义选项之一：

• 公司简介
  • 对其他市场参与者（最多 3 家公司）进行全面分析
  • 主要公司的SWOT分析（最多3家公司）
• 区域细分
  • 根据客户兴趣对主要国家/地区的市场估计/预测/复合年增长率（注：基于可行性检查）
• 竞争基准测试
  • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

内容

第 1 章执行摘要

第二章前言

• 概述
• 利益相关者
• 调查范围
• 调查方法
  • 数据挖掘
  • 数据分析
  • 数据验证
  • 研究方法
• 调查来源
  • 主要研究来源
  • 二手研究来源
  • 先决条件

第三章市场趋势分析

• 驱动程序
• 制约因素
• 机会
• 威胁
• 产品分析
• 最终用户分析
• 新兴市场
• 新冠肺炎 (COVID-19) 的影响

第 4 章波特五力分析

• 供应商的议价能力
• 买家的议价能力
• 替代品的威胁
• 新进入者的威胁
• 竞争公司之间存在敌对关係

第五章全球智能吸入器市场：按产品

• 吸入器
  • 干粉吸入器 (DPI)
  • 中剂量吸入器 (MDI)
• 雾化器

第六章全球智能吸入器市场：按适应症

• 哮喘
• 慢性阻塞性肺病 (COPD)

第七章全球智能吸入器市场：按分销渠道划分

• 医院药房
• 零售药店
• 网上药店

第 8 章全球智能吸入器市场：按最终用户划分

• 医院
• 家庭护理环境
• 呼吸护理中心
• 其他最终用户

第 9 章全球智能吸入器市场：按地区

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 意大利
  • 法国
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳大利亚
  • 新西兰
  • 韩国
  • 亚太地区其他地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东和非洲
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 卡塔尔
  • 南非
  • 其他中东和非洲地区

第 10 章主要进展

• 合同、伙伴关係、协作和合资企业
• 收购与合併
• 推出新产品
• 业务扩展
• 其他关键策略

第 11 章公司简介

• H&T Presspart Manufacturing Ltd.
• 3M Health Care Limited
• Adherium Limited
• AireHealth, Inc.
• Amiko Digital Health Limited
• AstraZeneca, Inc.
• Boehringer Ingelheim GmbH
• Cognita Labs, LLC
• Cohero Health LLC
• FindAir Sp. z o.o
• GlaxoSmithKline plc
• Novartis AG
• OPKO Health Inc
• Personal Air Quality Systems Private Limited
• Philip Morris International Inc.（Vectura Group Plc）
• Pneuma Respiratory, Inc.
• Propeller Health
• Teva Pharmaceuticals Industries Ltd.

According to Stratistics MRC, the Global Smart Inhalers Market is accounted for $1.42 billion in 2023 and is expected to reach $2.60 billion by 2030 growing at a CAGR of 9% during the forecast period. Smart inhalers are gadgets made to pair with a mobile app via Bluetooth in order to manage chronic respiratory conditions effectively and enhance patients lifestyles. Additionally, based on a user's past history of dosage administration, these smart devices are able to send reminders and alerts to them. Asthma, cystic fibrosis, and chronic obstructive pulmonary disorders, among other respiratory illnesses, are becoming more common, which has caused an exponential rise in the demand for smart inhalers.

According to the WHO 2021 report, asthma is a major noncommunicable disease (NCD), affecting both children and adults, and has affected an estimated 262 million people in 2019 and caused 461000 deaths in the same year.

Market Dynamics:

Driver:

Rising incidence of asthma

Asthma and COPD are becoming more common due to an increase in air pollution and smoking habits, which is driving market demand for smart inhalers. The ODPHP Office of Disease Prevention and Health Promotion estimates that there will be over 339 million asthma patients worldwide in 2020, of whom 25 million are Americans with a COPD diagnosis of 14.8 million. Asthma is the most prevalent disease among children and the elderly. This non-communicable disease is spreading due to an increase in smoking habits and rising levels of global air pollution.

Restraint:

Risk of data leakage

The risk of data leakage and misuse has increased significantly as a result of smart inhalers' wireless connectivity and ability to record the patient's data. Additionally, the smart inhaler has a very low level of patient and physician acceptance, which is anticipated to impede market expansion.

Opportunity:

Growing Use of digital technology in medical devices

During the forecast period, it is anticipated that rising digital technology adoption in medical devices and the effectiveness of drug delivery devices in therapeutic measures will accelerate market growth. In addition to this, it is predicted that an increase in the prevalence of respiratory conditions like asthma and COPD will present a significant opportunity for the increased adoption of digital inhalers. For instance, a study by the Centers for Disease Control and Prevention (CDC) estimated that in 2016, there were 26.5 million asthma sufferers in the United States. The aforementioned factors will significantly fuel the market expansion of these smart inhalers.

Threat:

Existence of alternative manual inhalers

Despite the growing benefits of smart inhalers, the availability of manual inhalers as a substitute product may limit market expansion to some extent. Another significant factor impeding the market expansion of smart inhalers is the lack of awareness regarding the use of digital inhalers among the populace of developing economies.

COVID-19 Impact:

The global COVID-19 outbreak is anticipated to present lucrative growth opportunities for market participants in the smart inhaler space. Due to the high risk of hospitalization from COVID-19 for patients with COPD and asthma, the pandemic had a positive effect on the market. Thus, the demand for or adoption of smart inhalers is rising at this time due to rising COVID-19 cases and the burden of respiratory disorders.

The hospitals pharmacies segment is expected to be the largest during the forecast period:

In the forecasted time frame, it is predicted that the hospital pharmacies segment will account for the largest market share. The patient population receiving treatments in hospital settings has easy access to hospital pharmacies. Additionally, a number of manufacturers of smart drug delivery systems have distribution agreements with these hospital pharmacies. Therefore, during the projection period, the aforementioned factors strongly suggest a positive growth trajectory for the market for hospital pharmacies that sell smart inhalers.

The chronic obstructive pulmonary disease (COPD) segment is expected to have the highest CAGR during the forecast period:

Due to expanding COPD patient populations worldwide, the market growth is anticipated to witness lucrative growth in the coming years. For instance, the World Health Organization estimates that the third leading cause of death worldwide in 2019 was COPD, which claimed the lives of over 3.23 million people. Furthermore, a number of risk factors, including prolonged tobacco use, indoor air pollution, harmful gases and particles, and occupational dust, influence the prevalence of COPD and necessitate ongoing care management. As a result, segmental demand will be driven over the anticipated period by the rising prevalence rate of COPD and the rising need for effective treatment.

Region with largest share:

The North America region market is estimated to witness the highest share of the global Smart Shelves market during the forecast period, which is attributed to increasing activities by key market players in countries in this region. The smart shelves market in North America involves the adoption and deployment of intelligent shelving systems that incorporate advanced technologies to enhance the shopping experience, improve inventory management, and provide real-time data analytics in retail environments. Retailers in North America are increasingly embracing automation and digitalization to streamline their operations and enhance customer engagement. Smart shelves offer real-time inventory tracking, enabling retailers to optimize stock levels, reduce out-of-stock situations, and improve overall inventory management efficiency.

Region with highest CAGR:

Due to its large elderly population, rising disposable incomes, rising healthcare costs, and numerous developmental initiatives, the Asia-Pacific region is expected to experience rapid growth. Regional growth will be aided by emerging economies' rising healthcare IT development expenditures. In addition, the markets for smart inhalers in Asia-Pacific are predicted to grow rapidly in India and China.

Key players in the market

Some of the key players profiled in the Smart Inhalers Market include H&T Presspart Manufacturing Ltd., 3M Health Care Limited, Adherium Limited, AireHealth, Inc., Amiko Digital Health Limited, AstraZeneca, Inc., Boehringer Ingelheim GmbH, Cognita Labs, LLC, Cohero Health LLC, FindAir Sp. z o.o, GlaxoSmithKline plc, Novartis AG, OPKO Health Inc, Personal Air Quality Systems Private Limited, Philip Morris International Inc. (Vectura Group Plc), Pneuma Respiratory, Inc., Propeller Health and Teva Pharmaceuticals Industries Ltd.

Key Developments:

In June 2023, H&T Presspart plans more investment in L'Arboc. The global supply of Ventolin metered-dose inhaler actuators are manufactured in in L'Arboc (Baix Penedes), Tarragona. With a combined annual production of more than 1,000 million units of injection-moulded plastic drug delivery components and devices, H&T Presspart has invested more than 20 million euros in its factory in L'Arboc in the last two years to expand its production capacity up to 3,000 square meters of cleanroom production facilities, with which to carry out new projects as they anticipate strong growth in the coming years.

In February 2023, Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that new data on its Digihaler System will be presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting, being held February 24-27 in San Antonio, Texas. The data includes findings from the CONNECT2 clinical trial program as well as information on patients and healthcare professionals' real-world use of the smart inhaler system. The Digihaler System is the first and only smart inhaler system with built-in sensors that provide objective inhaler event data to help patients and their doctors support asthma management and develop personalized treatment plans.

In December 2022, Australian medical cannabis company ECS Botanics has announced it will be supplying a vaporiser device for use with medicinal dried flower. The company says it has signed an agreement to import and supply a Smart Inhaler and associated software from an as yet un-named company that will provide metered-dose administration.

Products Covered:

• Inhalers
• Nebulizers

Indications Covered:

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

Distribution Channels Covered:

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

End Users Covered:

• Hospitals
• Homecare Settings
• Respiratory Care Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Smart Inhalers Market, By Product

• 5.1 Introduction
• 5.2 Inhalers
  • 5.2.1 Dry Powdered Inhalers (DPIs)
  • 5.2.2 Metered Dose Inhalers (MDI's)
• 5.3 Nebulizers

6 Global Smart Inhalers Market, By Indication

• 6.1 Introduction
• 6.2 Asthma
• 6.3 Chronic Obstructive Pulmonary Disease (COPD)

7 Global Smart Inhalers Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Hospitals Pharmacies
• 7.3 Retail Pharmacies
• 7.4 Online Pharmacies

8 Global Smart Inhalers Market, By End User

• 8.1 Introduction
• 8.2 Hospitals
• 8.3 Homecare Settings
• 8.4 Respiratory Care Centers
• 8.5 Other End Users

9 Global Smart Inhalers Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 H&T Presspart Manufacturing Ltd.
• 11.2 3M Health Care Limited
• 11.3 Adherium Limited
• 11.4 AireHealth, Inc.
• 11.5 Amiko Digital Health Limited
• 11.6 AstraZeneca, Inc.
• 11.7 Boehringer Ingelheim GmbH
• 11.8 Cognita Labs, LLC
• 11.9 Cohero Health LLC
• 11.10 FindAir Sp. z o.o
• 11.11 GlaxoSmithKline plc
• 11.12 Novartis AG
• 11.13 OPKO Health Inc
• 11.14 Personal Air Quality Systems Private Limited
• 11.15 Philip Morris International Inc. (Vectura Group Plc)
• 11.16 Pneuma Respiratory, Inc.
• 11.17 Propeller Health
• 11.18 Teva Pharmaceuticals Industries Ltd.

List of Tables

• Table 1 Global Smart Inhalers Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 4 Global Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 5 Global Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 6 Global Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 7 Global Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 8 Global Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 9 Global Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 10 Global Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 11 Global Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 12 Global Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 13 Global Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 14 Global Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 15 Global Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 16 Global Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 17 Global Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 18 Global Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 19 North America Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 20 North America Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 21 North America Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 22 North America Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 23 North America Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 24 North America Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 25 North America Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 26 North America Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 27 North America Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 28 North America Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 29 North America Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 30 North America Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 31 North America Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 32 North America Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 33 North America Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 34 North America Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 35 North America Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 36 North America Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 37 Europe Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 38 Europe Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 39 Europe Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 40 Europe Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 41 Europe Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 42 Europe Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 43 Europe Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 44 Europe Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 45 Europe Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 46 Europe Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 47 Europe Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 48 Europe Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 49 Europe Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 50 Europe Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 51 Europe Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 52 Europe Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 53 Europe Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 54 Europe Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 55 Asia Pacific Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 56 Asia Pacific Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 57 Asia Pacific Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 58 Asia Pacific Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 59 Asia Pacific Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 60 Asia Pacific Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 61 Asia Pacific Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 62 Asia Pacific Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 63 Asia Pacific Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 64 Asia Pacific Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 65 Asia Pacific Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 66 Asia Pacific Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 67 Asia Pacific Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 68 Asia Pacific Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 69 Asia Pacific Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 70 Asia Pacific Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 71 Asia Pacific Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 72 Asia Pacific Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 73 South America Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 74 South America Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 75 South America Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 76 South America Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 77 South America Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 78 South America Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 79 South America Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 80 South America Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 81 South America Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 82 South America Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 83 South America Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 84 South America Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 85 South America Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 86 South America Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 87 South America Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 88 South America Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 89 South America Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 90 South America Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 91 Middle East & Africa Smart Inhalers Market Outlook, By Country (2021-2030) ($MN)
• Table 92 Middle East & Africa Smart Inhalers Market Outlook, By Product (2021-2030) ($MN)
• Table 93 Middle East & Africa Smart Inhalers Market Outlook, By Inhalers (2021-2030) ($MN)
• Table 94 Middle East & Africa Smart Inhalers Market Outlook, By Dry Powdered Inhalers (DPIs) (2021-2030) ($MN)
• Table 95 Middle East & Africa Smart Inhalers Market Outlook, By Metered Dose Inhalers (MDI's) (2021-2030) ($MN)
• Table 96 Middle East & Africa Smart Inhalers Market Outlook, By Nebulizers (2021-2030) ($MN)
• Table 97 Middle East & Africa Smart Inhalers Market Outlook, By Indication (2021-2030) ($MN)
• Table 98 Middle East & Africa Smart Inhalers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 99 Middle East & Africa Smart Inhalers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 100 Middle East & Africa Smart Inhalers Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 101 Middle East & Africa Smart Inhalers Market Outlook, By Hospitals Pharmacies (2021-2030) ($MN)
• Table 102 Middle East & Africa Smart Inhalers Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
• Table 103 Middle East & Africa Smart Inhalers Market Outlook, By Online Pharmacies (2021-2030) ($MN)
• Table 104 Middle East & Africa Smart Inhalers Market Outlook, By End User (2021-2030) ($MN)
• Table 105 Middle East & Africa Smart Inhalers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 106 Middle East & Africa Smart Inhalers Market Outlook, By Homecare Settings (2021-2030) ($MN)
• Table 107 Middle East & Africa Smart Inhalers Market Outlook, By Respiratory Care Centers (2021-2030) ($MN)
• Table 108 Middle East & Africa Smart Inhalers Market Outlook, By Other End Users (2021-2030) ($MN)